Powell Anaesthesia Ltd 15197825 false 2023-10-09 2024-10-31 2024-10-31 The principal activity of the company is specialist medical practice activities Digita Accounts Production Advanced 6.30.9574.0 true 15197825 2023-10-09 2024-10-31 15197825 2024-10-31 15197825 core:RetainedEarningsAccumulatedLosses 2024-10-31 15197825 core:ShareCapital 2024-10-31 15197825 core:CurrentFinancialInstruments core:WithinOneYear 2024-10-31 15197825 bus:SmallEntities 2023-10-09 2024-10-31 15197825 bus:AuditExemptWithAccountantsReport 2023-10-09 2024-10-31 15197825 bus:FilletedAccounts 2023-10-09 2024-10-31 15197825 bus:SmallCompaniesRegimeForAccounts 2023-10-09 2024-10-31 15197825 bus:RegisteredOffice 2023-10-09 2024-10-31 15197825 bus:Director1 2023-10-09 2024-10-31 15197825 bus:PrivateLimitedCompanyLtd 2023-10-09 2024-10-31 15197825 bus:Agent1 2023-10-09 2024-10-31 15197825 countries:EnglandWales 2023-10-09 2024-10-31 iso4217:GBP xbrli:pure

Registration number: 15197825

Powell Anaesthesia Ltd

Unaudited Abridged Financial Statements

(Companies House version)

for the Period from 9 October 2023 to 31 October 2024

 

Powell Anaesthesia Ltd

Contents

Accountants' Report

1

Abridged Balance Sheet

2

Notes to the Unaudited Abridged Financial Statements

3 to 4

 

Chartered Accountants' Report to the Director on the Preparation of the Unaudited Statutory Accounts of
Powell Anaesthesia Ltd
for the Period Ended 31 October 2024

In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the accounts of Powell Anaesthesia Ltd for the period ended 31 October 2024 as set out on pages 2 to 4 from the company's accounting records and from information and explanations you have given us.

As a practising member firm of the Institute of Chartered Accountants in England and Wales (ICAEW), we are subject to its ethical and other professional requirements which are detailed at http://www.icaew.com/en/members/regulations-standards-and-guidance/.

This report is made solely to the Board of Directors of Powell Anaesthesia Ltd, as a body, in accordance with the terms of our engagement letter. Our work has been undertaken solely to prepare for your approval the accounts of Powell Anaesthesia Ltd and state those matters that we have agreed to state to the Board of Directors of Powell Anaesthesia Ltd, as a body, in this report in accordance with ICAEW Technical Release 07/16 AAF. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than Powell Anaesthesia Ltd and its Board of Directors as a body for our work or for this report.

It is your duty to ensure that Powell Anaesthesia Ltd has kept adequate accounting records and to prepare statutory accounts that give a true and fair view of the assets, liabilities, financial position and profit of Powell Anaesthesia Ltd. You consider that Powell Anaesthesia Ltd is exempt from the statutory audit requirement for the period.

We have not been instructed to carry out an audit or a review of the accounts of Powell Anaesthesia Ltd. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory accounts.

......................................

Page Kirk LLP
Chartered accountants and chartered tax advisers
Sherwood House
7 Gregory Boulevard
Nottingham
NG7 6LB

22 May 2025

 

Powell Anaesthesia Ltd

(Registration number: 15197825)
Abridged Balance Sheet as at 31 October 2024

Note

2024

   

£

£

Current assets

   

Cash at bank and in hand

   

4,563

Creditors: Amounts falling due within one year

 

(2,343)

Net assets

   

2,220

Capital and reserves

   

Called up share capital

1

 

Profit and loss account

2,219

 

Total equity

   

2,220

For the financial period ending 31 October 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

The members have not required the company to obtain an audit of its accounts for the period in question in accordance with section 476; and

The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

All of the company’s members have consented to the preparation of an Abridged Balance Sheet in accordance with Section 444(2A) of the Companies Act 2006.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the director has not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the director on 22 May 2025
 

.........................................
Dr A L Powell
Director

 

Powell Anaesthesia Ltd

Notes to the Unaudited Abridged Financial Statements for the Period from 9 October 2023 to 31 October 2024

1

General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
16 Florin Drive
Knaresborough
Yorkshire
HG5 0WG

These financial statements were authorised for issue by the director on 22 May 2025.

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Basis of preparation of financial statements

These financial statements were prepared under the historical cost convention in accordance with applicable United Kingdom accounting standards, including the Financial Reporting Standard 102 ('FRS 102') Section 1A small entities, and with the Companies Act 2006.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.

The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.

Tax

The tax expense for the period comprises current tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

 

Powell Anaesthesia Ltd

Notes to the Unaudited Abridged Financial Statements for the Period from 9 October 2023 to 31 October 2024

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.

Trade creditors are recognised initially at the transaction price and subsequently measured at amortised cost using the effective interest method.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

Dividends

Dividend distribution to the company’s shareholders is recognised as a liability in the financial statements in the reporting period in which the dividends are declared.

3

Staff numbers

During the period, the average number of employees at the company was 1.